HOOKIPA Pharma Inc. Sustainability Profile
HOOKIPA Pharma Inc., headquartered in the United States, is a pioneering biotechnology company focused on developing innovative immunotherapies for cancer and infectious diseases. Founded in 2011, HOOKIPA has made significant strides in the field, particularly with its proprietary platform that harnesses the power of viral vectors to stimulate robust immune responses. The company operates primarily in the oncology and infectious disease sectors, offering unique therapies that stand out for their ability to target specific antigens effectively. HOOKIPA's lead product candidates, including its promising therapies in clinical trials, exemplify its commitment to advancing treatment options. With a strong market position and notable achievements in research and development, HOOKIPA Pharma continues to be at the forefront of biopharmaceutical innovation, striving to improve patient outcomes globally.
DitchCarbon Score
How does HOOKIPA Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HOOKIPA Pharma Inc.'s score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HOOKIPA Pharma Inc.'s reported carbon emissions
HOOKIPA Pharma Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As such, HOOKIPA Pharma's climate commitments and initiatives remain unspecified, and there is no inherited emissions data from a parent or related organization. The company appears to be in the early stages of establishing its climate strategy within the pharmaceutical industry context.
How Carbon Intensive is HOOKIPA Pharma Inc.'s Industry?
How Carbon Intensive is HOOKIPA Pharma Inc.'s Location?
HOOKIPA Pharma Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
HOOKIPA Pharma Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
